By Bryan Koenig ( August 22, 2023, 9:01 PM EDT) -- Amgen and Horizon Therapeutics urged an Illinois federal judge not to let the Federal Trade Commission block their planned $27.8 billion merger, arguing in a brief unsealed Tuesday that FTC fears that the companies could anti-competitively protect Horizon drugs from rivals are entirely hypothetical and make no sense. ...
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.